Biomarker-driven Drug Development for Allergic Diseases and Asthma – Public Workshop
Zoom - VirtualThe Food and Drug Administration (FDA) is announcing a 1-day public workshop, regarding development and use of biomarkers in the regulation of allergenics to treat respiratory and food allergies. This public workshop is intended to be a forum for the exchange of information and perspectives among regulators and academic investigators on the use of biomarkers […]